我院肿瘤患者人血白蛋白临床应用分析

发布时间：2018-04-19 11:05

本文选题：肿瘤 + 人血白蛋白　；参考：《中国药房》2015年20期

【摘要】：目的:为临床合理使用人血白蛋白提供参考。方法:采用回顾性分析方法,抽取郑州大学附属肿瘤医院2014年1-6月应用人血白蛋白的256例住院肿瘤患者病历,对人均用药量、平均用药疗程、用药前患者血清白蛋白浓度等进行统计、分析。结果:我院人血白蛋白的使用范围涉及全院15个临床科室,主要以非手术科室为主;患者单次用量为10~20 g不等;术后低蛋白血症患者人均日用量最高,为15.82 g/d;低蛋白血症伴胸、腹水患者平均用药疗程最长,为6.93 d;用药原因均为低蛋白血症。结论:我院人血白蛋白的使用符合药品说明书及河南省医保机构的规定,但尚不符合北京市医保机构和美国大学医院联合会相关指南/指导原则的规定,因此关于人血白蛋白的使用指征需进一步明确;对于营养不良型低蛋白血症患者应重视营养的供给。
[Abstract]:Objective: to provide reference for the rational use of human serum albumin (HSA) in clinic.Methods: the medical records of 256 hospitalized cancer patients who were treated with human serum albumin from January to June 2014 in the affiliated Cancer Hospital of Zhengzhou University were selected by retrospective analysis.The serum albumin concentration of patients before treatment was statistically analyzed.Results: the range of application of human serum albumin in our hospital involved 15 clinical departments of the whole hospital, mainly non-operative departments, the dosage of single time was 10 ~ 20 g, the daily consumption of postoperative hypoproteinemia patients was the highest, 15.82 g / d, hypoproteinemia with chest,The average course of treatment in ascites patients was 6.93 days, and the reasons were hypoproteinemia.Conclusion: the use of human serum albumin in our hospital is in accordance with the drug specification and the regulations of Henan medical insurance organization, but it does not accord with the relevant guidelines / guidelines of Beijing medical insurance organization and American university hospital federation.Therefore, the indications of human serum albumin use should be further clarified, and attention should be paid to nutrition supply in patients with malnutrition hypoproteinemia.
【作者单位】：郑州大学附属肿瘤医院药学部;郑州市中心医院药剂科;
【基金】：河南省医学科技攻关计划项目(No.201303188)
【分类号】：R95

【参考文献】